This inventor holds 32 USPTO granted patents, primarily in Vascular Biology. Top assignees: The General Hospital Corporation, Harvard College, Bristol-Myers Squibb Compnay. Active years: 1977-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Weston, MA (US) (1977 - 1994)
- New York, NY (US) (1994)
- Princeton, NJ (US) (1995)
- late of Salisbury, NH (US) (2001)
- Salisbury, NH (US) (1993 - 2003)
Company Filing History:
22 out of 3,073 
8 out of 3,075 
2 out of 3,742 
Years Active: 1977-2003
Areas of Expertise:
Title: Innovations and Contributions of Edgar Haber in Antibody Therapy
Introduction
Edgar Haber, based in Salisbury, NH, is an esteemed inventor with a remarkable portfolio of 32 patents. His innovative work primarily focuses on therapies aimed at addressing critical medical conditions, particularly myocardial infarction and blood clots.
Latest Patents
One of his significant recent patents includes the development of antibodies that bind to α2-antiplasmin crosslinked to fibrin, which do not inhibit plasma α2-antiplasmin. This groundbreaking invention provides a treatment for myocardial infarction and enhances clot lysis by administering an antibody directed toward α2-antiplasmin crosslinked to fibrin, in conjunction with a thrombolytic agent. This therapeutic approach significantly contributes to advancing medical treatments for patients experiencing severe blood clotting issues.
Career Highlights
Throughout his career, Edgar Haber has been associated with prestigious institutions such as The General Hospital Corporation and the President and Fellows of Harvard College. His role in these organizations has been instrumental in pushing the boundaries of medical research and therapeutic innovations.
Collaborations
Edgar has collaborated with notable colleagues, including Gary R. Matsueda and Guy L. Reed. These partnerships have led to further advancements in the field of antibody research and the development of innovative medical therapies.
Conclusion
Edgar Haber's contributions to the field of biotechnology, particularly in the area of antibody therapy, showcase his dedication to innovation and improving patient outcomes. His extensive patent portfolio not only reflects his inventive spirit but also highlights the significant impact his work has on modern medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile